Ambulatorio di Allergologia, Clinica San Carlo, Paderno Dugnano (MI), Italy.
Allergy Asthma Clin Immunol. 2007 Mar 15;3(1):24-30. doi: 10.1186/1710-1492-3-1-24.
: In the large majority of previous studies, patients with a history of acute urticaria induced by nonsteroidal anti-inflammatory drugs (NSAIDs) seeking safe alternative drugs have undergone tolerance tests uniquely with compounds exerting little or no inhibitory effect on the cyclooxygenase 1 enzyme. In light of recently published studies, however, this approach seems inadequate and should be changed. The present article critically reviews the clinical management of patients presenting with a history of urticaria induced by a single NSAID or multiple NSAIDs and suggests a simple, updated diagnostic algorithm that may assist clinicians in correctly classifying their patients.
: 在之前的绝大多数研究中,有非甾体抗炎药(NSAIDs)诱导性急性荨麻疹病史、寻求安全替代药物的患者,进行了独特的耐受试验,仅使用对环氧化酶 1 酶几乎没有或没有抑制作用的化合物。然而,鉴于最近发表的研究,这种方法似乎不够充分,应该改变。本文批判性地回顾了单一 NSAID 或多种 NSAIDs 诱导性荨麻疹患者的临床处理方法,并提出了一个简单、更新的诊断算法,可能有助于临床医生正确分类患者。